Enzymatic process for the regioselective manufacturing of n-fmoc-doxorubicin- 14-o-dicarboxylic acid mono esters
AU2011204918A1
Use of alkylphosphocholines in combination with antitumor medicaments
EP2508184A1
Pyridopyrazine derivatives and their use
US2011243933A1
Perifosine and capecitabine as a combined treatment for cancer
EP2431035A1
Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
US2011028421A1
Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
EP2332939A1
Novel Naphthyridine derivatives and the use thereof as kinase inhibitors
EP2266567A1
Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
EP2266568A1
Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
EP2241557A1
Chinoxalin derivatives and use thereof for treating malignant and benign tumour illnesses
IL197127D0
Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
WO2009098246A1
Recombinant bacteria with e. coli hemolysin secretion system and increased expression and/or secretion of hlya, process of manufacturing and uses thereof
EP2103602A1
Novel 1,2,4-triazole derivatives and process of manufacturing thereof
EP2095818A1
Use of LHRH antagonists at non-castrating doses
EP2085466A1
Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof
BRPI0716190A2
Disorazole conjugates and its derivatives with cellular connection modules, disorazole derivatives, processes for the manufacture and use of the same
US2008051463A1
Anthracene compounds and their use for treating benign and malignant tumor disorders
WO2008015265A1
Anthracen derivatives and their use for the treatment of benign and malignant tumorous diseases
EP1990342A1
Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof
EP1988098A1
Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
